A new study has found that the clot-dissolving drug alteplase can significantly improve stroke recovery even when given up to ...

In young stroke populations, illicit drug use has been reported in 12 ... For longer term secondary stroke prevention, antiplatelet agents, control of vascular risk factors, and, most importantly ...

Although short-term dual antiplatelet therapy may eventually prove to benefit specific populations with very high stroke risk, the SPS3 trial definitively establishes that lacunar stroke alone is ...

these medications reduce the risk of clot-related conditions such as heart attack, stroke, and peripheral artery disease. When it comes to dosing, the effectiveness and safety of antiplatelet ...

Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with ...

These results give hope to stroke patients worldwide who may not be able to access clot-dissolving medications within the approved time window ... while the other received standard stroke care of ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

Long-term dual antiplatelet therapy has not been rigorously assessed in patients with specific ischemic stroke subtypes other than that associated with atrial fibrillation (JW Neurol Aug 11 2009).

A recent study from Chinese researchers reveals that alteplase, a clot-busting medication, can significantly improve recovery outcomes for stroke patients, increasing chances of recovery by over 50% ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual ...